articleExperimental Hematology and OncologyApr 12, 2024GOLD OA

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion

Tongji Hospital · Huazhong University of Science and Technology · +2 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Paradoxically, tumor development and progression can be inhibited and promoted by the immune system. After three stages of immune editing, namely, elimination, homeostasis and escape, tumor cells are no longer restricted by immune surveillance and thus develop into clinical tumors. The mechanisms of immune escape include abnormalities in antitumor-associated immune cells, selection for immune resistance to tumor cells, impaired transport of T cells, and the formation of an immunosuppressive tumor microenvironment. A population of distinct immature myeloid cells, myeloid-derived suppressor cells (MDSCs), mediate immune escape primarily by exerting immunosuppressive effects and participating in the constitution…

Citation impact

137
total citations
FWCI
29.62
Percentile
100%
References
230
Citations per year

Authors

11

Topics & keywords

Keywords
  • Immune system
  • Immunotherapy
  • Myeloid-derived Suppressor Cell
  • Tumor microenvironment
  • Immunology
  • Cancer research
  • Medicine
  • Population
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding